Indonesian perspective on biomaterials and medical devices

Ferdiansyah Mahyudin, Sulistioso Giat Sukaryo, Widowati Siswomihardjo, Hendra Hermawan

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

3 Citations (Scopus)


Indonesia is an emerging country with population about 255 million in 2015 and 40% of this population is in their productive age. The country’s nominal GDP for 2015 is about 900 billion USD with 5% annual growth and general government debt stays at 26% of GDP. The government has put healthcare service as one of the strategic program in the 2015–2019 National Development Plan along with a new effective national healthcare financing scheme. Indonesia is a big market for medical products with a market value about 800 million USD in 2015 and estimated to reach 1.2 billion USD in 2019. The government has set policies and a clear roadmap for assuring the availability and distribution of medical devices by fostering local production, improving the quality of local products and tightening the surveillance to the pre- and post-market devices. The challenge lies on unifying the country’s experts to mutually collaborate under a strong leadership on the same interest toward the national independency in producing effective yet low cost medical devices.

Original languageEnglish
Title of host publicationAdvanced Structured Materials
PublisherSpringer Verlag
Number of pages8
Publication statusPublished - 1 Mar 2016
Externally publishedYes

Publication series

NameAdvanced Structured Materials
ISSN (Print)1869-8433
ISSN (Electronic)1869-8441


  • Biomaterials
  • Indonesian government
  • Market
  • Medical devices
  • Policy
  • Regulation


Dive into the research topics of 'Indonesian perspective on biomaterials and medical devices'. Together they form a unique fingerprint.

Cite this